189 related articles for article (PubMed ID: 28858837)
41. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
[TBL] [Abstract][Full Text] [Related]
43. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
44. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies.
Shete H; Chatterjee S; De A; Patravale V
Int J Pharm; 2013 Sep; 454(1):584-92. PubMed ID: 23535344
[TBL] [Abstract][Full Text] [Related]
45. Dual Nanostructured Lipid Carriers/Hydrogel System for Delivery of Curcumin for Topical Skin Applications.
Calderon-Jacinto R; Matricardi P; Gueguen V; Pavon-Djavid G; Pauthe E; Rodriguez-Ruiz V
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740905
[TBL] [Abstract][Full Text] [Related]
46. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
47. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
Madane RG; Mahajan HS
Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
[TBL] [Abstract][Full Text] [Related]
48. Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line.
Singh P; Singh M; Kanoujia J; Arya M; Saraf SK; Saraf SA
Drug Deliv Transl Res; 2016 Oct; 6(5):597-609. PubMed ID: 27431400
[TBL] [Abstract][Full Text] [Related]
49. Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo.
Han C; Li Y; Sun M; Liu C; Ma X; Yang X; Yuan Y; Pan W
Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):161-6. PubMed ID: 23731383
[TBL] [Abstract][Full Text] [Related]
50. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.
Zhang XY; Qiao H; Ni JM; Shi YB; Qiang Y
Eur J Pharm Sci; 2013 Jun; 49(3):411-22. PubMed ID: 23624327
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
Alkhader E; Roberts CJ; Rosli R; Yuen KH; Seow EK; Lee YZ; Billa N
J Biomater Sci Polym Ed; 2018 Dec; 29(18):2281-2298. PubMed ID: 30376409
[TBL] [Abstract][Full Text] [Related]
52. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition.
Rapalli VK; Kaul V; Waghule T; Gorantla S; Sharma S; Roy A; Dubey SK; Singhvi G
Eur J Pharm Sci; 2020 Sep; 152():105438. PubMed ID: 32598913
[TBL] [Abstract][Full Text] [Related]
53. Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.
Abdolahpour S; Toliyat T; Omidfar K; Modjtahedi H; Wong AJ; Rasaee MJ; Kashanian S; Paknejad M
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):89-94. PubMed ID: 28296511
[TBL] [Abstract][Full Text] [Related]
54. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z
Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346
[TBL] [Abstract][Full Text] [Related]
55. Nanostructured lipid carriers as a delivery system of biochanin A.
Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
[TBL] [Abstract][Full Text] [Related]
56. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
57. In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration.
Fang M; Jin Y; Bao W; Gao H; Xu M; Wang D; Wang X; Yao P; Liu L
Int J Nanomedicine; 2012; 7():5395-404. PubMed ID: 23091382
[TBL] [Abstract][Full Text] [Related]
58. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ
Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098
[TBL] [Abstract][Full Text] [Related]
59. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats.
Tan JSL; Roberts C; Billa N
J Biomater Sci Polym Ed; 2020 Feb; 31(2):141-154. PubMed ID: 31612804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
